Taxol and Aggrenox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Taxol (paclitaxel) and Aggrenox (aspirin; dipyridamole). Common drug interactions include dehydration among females and arteriosclerosis among males.

The phase IV clinical study analyzes what interactions people have when they take Taxol and Aggrenox. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Taxol?

Taxol has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 33,554 Taxol users. Check the latest studies of Taxol.

What is Aggrenox?

Aggrenox has active ingredients of aspirin; dipyridamole. It is often used in stroke. eHealthMe is studying from 7,654 Aggrenox users. Check the latest studies of Aggrenox.



On Jul, 19, 2026

15 people who take Taxol and Aggrenox together, and have interactions are studied.

Taxol and Aggrenox drug interactions.

What are the common drug interactions of Taxol and Aggrenox, by gender? *:

female:

  1. Dehydration (dryness resulting from the removal of water)
  2. Diarrhoea
  3. Hypotension (abnormally low blood pressure)
  4. Renal failure acute (rapid kidney dysfunction)

male:

  1. Arteriosclerosis (thickening and hardening of arteries)
  2. Fall
  3. Nocturia (the need to get up in the night to urinate)
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Abdominal hernia
  6. Abdominal pain
  7. Abdominal pain upper
  8. Anaemia (lack of blood)
  9. Back pain
  10. Bacterial infection

What are the common drug interactions of Taxol and Aggrenox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Arteriosclerosis (thickening and hardening of arteries)
  2. Fall
  3. Nocturia (the need to get up in the night to urinate)
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Hypotension (abnormally low blood pressure)
  6. Abdominal hernia
  7. Abdominal pain
  8. Abdominal pain upper
  9. Anaemia (lack of blood)
  10. Back pain

What are the existing conditions these people have? *

  1. Prostate Cancer: 8 people, 53.33%
  2. Osteoporosis (bones weak and more likely to break): 8 people, 53.33%
  3. High Blood Cholesterol: 8 people, 53.33%
  4. Type 2 Diabetes: 6 people, 40.00%
  5. High Blood Pressure: 6 people, 40.00%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 40.00%
  7. Bladder Cancer: 6 people, 40.00%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 13.33%
  9. Lung Cancer - Non-Small Cell (lung cancer): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Taxol and Aggrenox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Taxol and Aggrenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Taxol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aggrenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Taxol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aggrenox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on paclitaxel and aspirin; dipyridamole (the active ingredients of Taxol and Aggrenox, respectively), and Taxol and Aggrenox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: